Ability to understand and the willingness to provide written informed consent to participate
Subject has the ability to understand and provide signed informed consent
Male or female, ? 18 years old with the ability to understand and provide signed and witnessed informed consent, and agree to comply with protocol requirements
Ability to understand the nature of this study and give written informed consent.
Ability to provide and understand written informed consent prior to any study procedures
Ability to understand and willing to provide informed consent
Ability to understand the nature of this trial and give written informed consent.
Ability to understand and willingness to provide informed consent
Ability to understand and willingness to provide informed consent.
Ability to understand and provide signed informed consent
Ability to understand and provide informed consent
Ability to understand and provide informed consent
Patient has the ability to understand and provide signed informed consent
Ability to understand and the willingness to provide informed consent
Ability to understand and provide informed consent
Ability to understand and provide informed consent
INCLUSION CRITERIA FOR PATIENTS WITH NSCLC OR TNBC (COHORT B): Ability to understand and provide informed consent
INCLUSION CRITERIA FOR TNBC: Ability to understand and provide informed consent
Ability to understand and provide signed informed consent
Patient must have the ability to understand the requirements of the study and provide informed consent.
Patient has the ability to understand and provide signed informed consent
Ability to understand and provide signed informed consent
Ability to understand and the willingness to provide written informed consent
Ability to understand and the willingness to sign a written informed consent document, and willing to provide blood samples before and during preoperative therapy; patients are also asked but not required to have research biopsies performed before and after therapy
Ability to understand and provide signed informed consent that fulfills Institutional Review Board’s guidelines
Ability to understand and provide informed consent
Ability to understand and willingness to give informed consent
Ability to understand the requirements of the study, provide written informed consent.
Ability to provide written informed consent and to understand and comply with the requirements of the study
Ability to understand and willingness to provide informed consent.
Ability to understand a written informed consent
Ability to understand and provide voluntary written informed consent
Ability to understand and willingness to provide informed consent, and the willingness to comply with the requirements of the protocol; informed consent may be obtained with the assistance of a medical translator according to institutional policies
Ability to understand and the willingness to provide written informed consent
Ability to understand and the willingness to provide informed consent
Ability to understand and provide written informed consent
Ability to provide and understand written informed consent prior to any study procedures
Ability to understand and the willingness to provide written informed assent or consent
Ability to understand the nature of this study and give written informed consent.
Patients must have the ability to understand and the willingness to provide signed written informed consent document
Ability to understand and the willingness to provide informed consent
Ability to understand the investigational nature of this study and to give informed consent
Ability to understand informed consent and signing of written informed consent document prior to initiation of protocol therapy
Ability to understand and provide informed consent
DONOR: Ability to understand and provide informed consent for all study procedures including partial liver transplant and bone marrow harvest
DONOR: Ability to understand and provide informed consent for all study procedures including liver transplant and bone marrow harvest
Ability to understand the nature of this study and give written informed consent.
Ability to understand the nature of this trial and give written informed consent
Must have the ability to understand and the willingness to provide a written informed consent to participate in the study
Ability to read, understand and provide written consent to participate in the study
Ability to understand and provide informed consent
DONOR: Ability to understand and provide informed consent for all study procedures including kidney transplant and bone marrow harvest
Patients with the ability to understand and give written informed consent for participation in this trial, including all evaluations and procedures as specified by this protocol.
Patients with the ability to understand and give written informed consent for participation in this trial, including all evaluations and procedures as specified by this protocol.
Ability to understand and the willingness to provide informed consent to participate
Ability to understand and complete written informed consent
Ability to understand and provide written informed consent to participate in this study.
This protocol is eligible for waiver of informed consent documentation; all subjects must have the ability to understand and the willingness to provide verbal informed consent
This protocol is eligible for waiver of informed consent documentation; all subjects must have the ability to understand and the willingness to provide verbal informed consent
All subjects must have the ability to understand and the willingness to participate in the informed consent process, although a waiver of written informed consent is obtained for this study
Ability to understand and the willingness to provide written informed consent
All participants must have the ability to understand the willingness to provide informed consent
All subjects must have the ability to understand and the willingness to participate in the informed consent process
This protocol is eligible for waiver of informed consent documentation; all subjects must have the ability to understand and the willingness to provide verbal informed consent
Ability to sign informed consent and understand the nature of a placebo-controlled trial
Ability to understand and the willingness to provide informed consent.
Ability to understand and give informed consent
Ability to understand and willingness to provide informed consent
Ability to understand and the willingness to provide informed consent
Ability to understand informed consent and signing of written informed consent prior to initiation of protocol therapy
Ability to understand the investigational nature of the study and provide informed consent
Have the ability to understand and to give written informed consent as assessed by the participant’s primary care physician or medical oncologist
Patient has the ability to understand and provide signed informed consent.
Ability to understand the nature of this trial and give written informed consent.
